OCON Therapeutics
Spherical Intrauterine Drug Delivery Platform
StartupOCON Therapeutics is a Modi'in-Maccabim-Re'ut-based startup in the Health Tech & Life Sciences sector, established in 2011. Spherical Intrauterine Drug Delivery Platform. The company has raised a total of $24.5M across 8 funding rounds, currently at the A stage. Key investors include Rhia Ventures, Exerte Partners, Features Capital, among 12 total investors. The company has 11-50 employees. Core technologies: Materials & Substances, Implants.
With $24.5M in total funding, OCON Therapeutics is a A-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2C business model. Product stage: Released. The company holds 1 patent.
- StageA
- ProductReleased
- ModelB2B, B2C
- Employees11-50
- HQModi'in-Maccabim-Re'ut
- Last Round$10M
- Rhia VenturesLead
- Exerte Partners
- Features Capital
12 investors total
21 articles covered by sources including www.calcalistech.com,
www.finsmes.com,
www.prnewswire.com,
www.themarker.com,
jewishbusinessnews.com.
What does OCON Therapeutics do?
OCON Therapeutics innovates, develops, manufactures, and commercializes women's health products based on its proprietary and patented intrauterine ball (IUB) platform. Made from the super-elastic alloy nitinol, the IUB is an ideal carrier of multiple drugs to the uterus for treating a variety of conditions. In addition to its flagship product, the IUB Ballerine, OCON Therapeutics is developing a pipeline of products utilizing the IUB frame for indications including abnormal uterine bleeding, heavy menstrual bleeding, myomas and fibroids, and infertility.
How much funding has OCON Therapeutics raised?
OCON Therapeutics has raised $24.5M in total funding across 8 rounds. The company is currently at the A stage. Key investors include Rhia Ventures, Exerte Partners, Features Capital.
What sector is OCON Therapeutics in?
OCON Therapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients, Commerce & Retail, Distribution Channels, Distributor, Consumers, Demographics & Family, Women.
Where is OCON Therapeutics located?
OCON Therapeutics is based in HaMiktsoot Blvd 14, Modi'in-Maccabim-Re'ut, Israel. The company also has offices abroad.